Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
19.53
-2.68 (-12.07%)
At close: Mar 31, 2025, 4:00 PM
19.74
+0.21 (1.08%)
After-hours: Mar 31, 2025, 7:58 PM EDT
Beam Therapeutics Market Cap
Beam Therapeutics has a market cap or net worth of $1.58 billion as of March 31, 2025. Its market cap has decreased by -46.16% in one year.
Market Cap
1.58B
Enterprise Value
894.79M
1-Year Change
-46.16%
Ranking
Category
Stock Price
$19.53
Market Cap Chart
Since February 6, 2020, Beam Therapeutics's market cap has increased from $327.97M to $1.58B, an increase of 383.00%. That is a compound annual growth rate of 35.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 1.80B | -8.73% |
| Dec 31, 2024 | 1.97B | -8.58% |
| Dec 29, 2023 | 2.16B | -19.78% |
| Dec 30, 2022 | 2.69B | -49.47% |
| Dec 31, 2021 | 5.33B | 15.54% |
| Dec 31, 2020 | 4.61B | 1,305.76% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |